(NYSE:AGL) NEW YORK, Sept. 3, 2025 August 6, 2025 (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...